Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Case ReportImages in Rheumatology

Severe Tophaceous Gout with Radiograph Examination of Diffused Calcified Soft Tissue Tophi

ERWAN OEHLER and TRISTAN PASCART
The Journal of Rheumatology July 2015, 42 (7) 1259-1260; DOI: https://doi.org/10.3899/jrheum.150181
ERWAN OEHLER
Department of Internal Medicine, Taaone Hospital, Pirae, Tahiti, French Polynesia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TRISTAN PASCART
Department of Rheumatology, Saint-Philibert Hospital, Lille Catholic University, Lomme, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pascart.tristan@ghicl.net

A 44-year-old man presented to our hospital with severe polyarticular familial gout. He experienced recurrent attacks on a monthly basis, and multiple tophaceous deformations appeared over the years as serum urate levels remained above 10 mg/dl in spite of a daily treatment by allopurinol 600 mg. This led to dramatic infirmity as demonstrated by the deformities because of tophi development (Figure 1), leaving him entirely dependent on his family for everyday care. The presented radiograph examination of the left foot demonstrated massive calcified soft tissue urate deposits and intrabone tophi (Figure 2). Parathormone, calcium, and phosphate levels were normal.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Tophaceous deformations of the left hand.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Plain radiography of diffuse calcified tophi of the left foot.

Prevalence of gout in Polynesia is high because of the combination of the adoption of occidental food diets and genetic predisposing factors, especially the mutation of renal urate transporter genes leading to decreased urate excretion1,2. Tophaceous gout affects 15% to 20% of patients with gout3. Tophi are classically radio-transparent4, but such case illustrates the possibility of associated calcic crystals, especially in cases of renal impairment such as the one affecting our patient (estimated glomerular filtration rate 47 ml/min). These calcifications could be the result of a persistent inflammation taking place within tophi as proven by histological studies5. Severe cases of tophaceous gout are responsible for joint destruction and severe disability. Prolonged treatment by urate-lowering therapies can maintain serum uric acid levels below urate crystallization levels and eventually deplete urate deposits, which ultimately leads to tophi regression.

REFERENCES

  1. 1.
    1. Flynn TJ,
    2. Phipps-Green A,
    3. Hollis-Moffatt JE,
    4. Merriman ME,
    5. Topless R,
    6. Montgomery G,
    7. et al.
    Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects. Arthritis Res Ther 2013;15:R220.
  2. 2.
    1. Simmonds HA,
    2. McBride MB,
    3. Hatfield PJ,
    4. Graham R,
    5. McCaskey J,
    6. Jackson M
    . Polynesian women are also at risk for hyperuricaemia and gout because of a genetic defect in renal urate handling. Br J Rheumatol 1994;33:932–7.
  3. 3.
    1. Dalbeth N,
    2. House ME,
    3. Horne A,
    4. Taylor WJ
    . Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with gout. BMC Musculoskelet Disord 2013;14:363.
  4. 4.
    1. Gentili A
    . The advanced imaging of gouty tophi. Curr Rheumatol Rep 2006;8:231–5.
  5. 5.
    1. Dalbeth N,
    2. Pool B,
    3. Gamble GD,
    4. Smith T,
    5. Callon KE,
    6. McQueen FM,
    7. et al.
    Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum 2010;62:1549–56.

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire